-
Exports are good, Vietnamese aquaculture companies set high profit targets this year
Time of Update: 2022-05-17
Vietnam's " Customs Online" reported on April 25 that many large-scale aquatic product enterprises in Vietnam achieved higher export revenue in the first few months of this year, so they set higher business plans than the previous year .
-
The net profit of listed fertilizer companies continues to surge
Time of Update: 2022-05-17
8% from the same period in 2020; the average market price of compound fertilizers It was 3,157 yuan, up 37% from the beginning of 2021 and 53.
-
Enjie plans to build a lithium battery diaphragm project
Time of Update: 2022-05-17
The company has established a lithium battery separator production base in Hungary, Europe.
-
News of executives of pharmaceutical companies in April: personnel changes in 3 multinational pharmaceutical companies!
Time of Update: 2022-05-17
Among them, Zhang Ying, president of Novartis Pharmaceuticals (China), was appointed as president and managing director of innovative drugs China.
-
The $100 billion rare disease drug market is "attractive", and pharmaceutical companies have stepped up to enter the "enclosure"
Time of Update: 2022-05-17
, the main indications are rare diseases and tumors, and the company is currently promoting the research projects to clinical research . In early January this year, AstraZeneca announced that its rare
-
In 4 months, a large number of presidents and vice presidents of pharmaceutical companies have resigned or replaced!
Time of Update: 2022-05-16
It is worth mentioning that on January 6, Buchang Pharmaceutical announced that the board of directors received a written resignation report submitted by the vice president of the company, Mr.
-
Breakthrough path under the epidemic situation with foreign companies in Shanghai
Time of Update: 2022-05-16
In the face of the severe epidemic prevention and control situation, how can chemical companies cooperate and respond quickly to ensure the safety of employees and the continuous and efficient operation of the supply chain?
-
Domestic and foreign pharmaceutical companies are rushing in, and the $100 billion market has become a "sweet pastry"
Time of Update: 2022-05-16
/>. However, in recent years, with the increasing attention of rare diseases in the industry and the continuous introduction of a series of favorable policies at home and abroad to encourage pharmaceutical companies
-
A group of executives of pharmaceutical companies are frequently "running away"!
Time of Update: 2022-05-16
Not long ago, AstraZeneca also issued an internal announcement: Lu Yanbin, the current deputy director of the Strategic Project Management Office, will leave the company to seek external development opportunities due to personal reasons .
-
Henan announced the sales of the top 100 pharmaceutical companies in the first quarter: Hengrui, Qilu, Chia Tai Tianqing...
Time of Update: 2022-05-16
" (hereinafter referred to as the "Notice") . >>The "Notice" announced the situation of drug production enterprises and operating enterprises in Henan Province
-
New trend of multinational pharmaceutical companies in China?
Time of Update: 2022-05-16
, at the 2022 annual meeting of the Boao Forum for Asia, Chengdu and the participating company AstraZeneca held an online signing ceremony for AstraZeneca's traditional Chinese medicine innovation industry base, marking the official settlement
-
The first chemical company in Jiangxi was recognized by RCEP
Time of Update: 2022-05-16
has become the first approved exporter under RCEP in Jiangxi Province after the approval of Nanchang Customs .
-
The competition in the pharmaceutical industry has intensified, and pharmaceutical companies are accelerating the divestment of some businesses
Time of Update: 2022-05-16
In recent years, under the background of accelerated changes in the pharmaceutical environment, many pharmaceutical companies have begun to adjust their development strategies, such as Roche, Eli
-
This pharmaceutical company has another new ADC drug for clinical application!
Time of Update: 2022-05-16
Specifically, BAT8009, which was also approved for clinical use in April, is a B7H3-targeting antibody-drug conjugate (ADC) developed by Bio-Tech, which is intended to be developed for the treatment of solid tumors .
-
of Saiding Engineering Company was successfully put into place
Time of Update: 2022-05-16
The absorption tower is the key equipment of the nitric acid plant, and this milestone marks that the KAN project has fully entered the process equipment installation stage .
-
Sinopec Zhongyuan Petroleum Engineering Company Saudi Service Support Squadron fully promotes
Time of Update: 2022-05-16
The picture shows that on April 9, the squadron dismantled and relocated the drilling equipment that had been completed in the construction area .
-
A large proportion of innovative pharmaceutical companies broke, and one company achieved "U-picking"
Time of Update: 2022-05-16
. Among them, China Cell stated that during the reporting period, the company's self-developed product Ancaine (SCT800, recombinant human coagulation factor VIII) was approved for listing in July 2021, and began to generate sales revenue continuously.
-
Nearly 80% of in vitro diagnostic companies reported good results, and 11 companies including Rejing Biotech increased by over 100% year-on-year
Time of Update: 2022-05-16
Among them, nearly 80% of the in vitro diagnostic companies reported good performance, and 11 companies saw a year-on-year increase of more than 100%, including Jimin Medical, Rejing Bio, Xinkaiyuan, Jiu'an Medical, Mingde Bio, Wantai Bio, and Oriental Bio .
-
LGES Stlantis joint venture to build lithium battery plant
Time of Update: 2022-05-16
Canadian automaker Stlantis Group and LG Energy Solutions (LGES) have announced a joint venture agreement to build the first large-scale electric vehicle battery manufacturing plant in Ontario, Canada .
-
The profits of leading machinery companies are public: Medtronic, Mindray, Weigao, Abbott...
Time of Update: 2022-05-15
192 billion yuan; tumor prevention and control business achieved revenue of 380 million yuan, a year-on-year increase of 8.
